Dibenzo-18-Crown-6 Synthesis Route Industrial Purity Manufacturing
- [Macrocycle Kinetics]: Optimized cyclization pathways ensure superior hydrophobicity and phase transfer efficiency compared to standard 18-crown-6 analogs.
- [Logistics Stability]: Factory-direct supply chains guarantee batch-to-batch consistency and secure tonnage quantities for continuous production lines.
- [GMP Scalability]: Rigorous quality control protocols align with international regulatory standards, supporting seamless scale-up from pilot to commercial runs.
In the landscape of advanced organic synthesis, macrocyclic ethers serve as critical enabling structures for complex transformations. Among these, Dibenzo-18-crown-6 (CAS: 14187-32-7) stands out due to its unique ability to complex alkali metal cations within non-polar organic media. For process chemists and procurement specialists alike, securing a reliable supply of this intermediate is paramount for maintaining reaction yields and minimizing downstream purification costs. As a premier global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. delivers process-scale purity tailored for pharmaceutical and industrial applications.
Optimizing the Synthesis Route for Maximum Yield
The synthesis route for Dibenzo-18-crown-6 typically involves the cyclization of catechol derivatives with polyethylene glycol dihalides under high-dilution conditions. However, achieving industrial purity requires meticulous control over reaction kinetics to prevent oligomerization and linear polymer formation. Our manufacturing process utilizes template-directed synthesis strategies that pre-organize the linear precursors, significantly enhancing the probability of macrocyclization.
From a technical perspective, the presence of benzo groups fused to the crown ether ring increases the molecule's hydrophobicity compared to unsubstituted 18-crown-6. This structural modification is crucial for extraction efficiency and phase transfer catalysis in room-temperature ionic liquids and conventional organic solvents. Data indicates that the distribution ratio for cesium and potassium complexes is markedly higher with the dibenzo derivative, facilitating cleaner reaction profiles in nucleophilic substitutions. When scaling this chemistry, controlling residual halides and unreacted glycols is essential to meet the stringent impurity profiles required for API synthesis.
Quality Parameters and Technical Specifications
Consistency is the cornerstone of industrial chemistry. Variations in purity can lead to unpredictable reaction rates or catalyst poisoning. The following table outlines the standard quality parameters maintained during our production cycles to ensure commercial grade reliability.
| Parameter | Specification | Test Method |
|---|---|---|
| CAS Number | 14187-32-7 | N/A |
| Chemical Name | 6,7,9,10,17,18,20,21-Octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecine | IUPAC |
| Purity (HPLC) | ≥ 99.0% | Area Normalization |
| Appearance | White to Off-white Crystalline Powder | Visual |
| Moisture Content | ≤ 0.5% | Karl Fischer |
| Heavy Metals | ≤ 10 ppm | ICP-MS |
Procurement Strategy and Supply Chain Resilience
For procurement managers, the stability of the supply chain is as critical as the chemical specification itself. Fluctuations in bulk price often correlate with raw material availability and energy costs associated with the manufacturing process. By maintaining robust inventory levels and vertical integration of key starting materials, we mitigate these risks. Clients sourcing Dibenzo-18-crown-6 from our facilities benefit from factory-direct advantages, eliminating intermediary markups and ensuring transparent communication regarding lead times.
Every shipment is accompanied by a comprehensive COA (Certificate of Analysis) verifying batch-specific data against internal standards. This documentation is vital for regulatory filings and quality assurance audits. Whether requiring kilogram samples for method development or tonnage quantities for commercial production, our logistics network supports timely delivery to major pharmaceutical hubs worldwide.
Regulatory Compliance and Commercial Viability
Executive decision-makers must weigh the commercial viability of any intermediate against regulatory hurdles. Our production facilities adhere to strict environmental and safety guidelines, ensuring that the manufacturing process complies with relevant international standards. The scalability of our synthesis allows for seamless transition from pilot plant to full-scale production without compromising the structural integrity of the macrocycle.
Furthermore, the versatility of 2,3,11,12-Dibenzo-1,4,7,10,13,16-hexaoxacyclooctadeca-2,11-diene extends beyond traditional catalysis into emerging fields such as ion-selective membrane technology and supramolecular assembly. Investing in a reliable supply partner ensures that R&D pipelines remain uninterrupted and that time-to-market for final drug products is optimized.
NINGBO INNO PHARMCHEM CO.,LTD. remains committed to empowering the pharmaceutical industry with high-quality intermediates. To discuss your specific requirements or to contact our technical sales team for a batch-specific COA, SDS, or bulk pricing quote, please reach out to us directly.